Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Comparison of mometasone furoate 0.1% ointment and betamethasone dipropionate 0, 05% ointment in the treatment of psoriasis vulgaris (CROSBI ID 149102)

Prilog u časopisu | stručni rad

Peharda, Vesna ; Gruber, Franjo ; Prpić, Larisa ; Kaštelan, Marija ; Brajac, Ines Comparison of mometasone furoate 0.1% ointment and betamethasone dipropionate 0, 05% ointment in the treatment of psoriasis vulgaris // Acta Dermatovenerologica Croatica, 8 (2000), 223-226

Podaci o odgovornosti

Peharda, Vesna ; Gruber, Franjo ; Prpić, Larisa ; Kaštelan, Marija ; Brajac, Ines

engleski

Comparison of mometasone furoate 0.1% ointment and betamethasone dipropionate 0, 05% ointment in the treatment of psoriasis vulgaris

A single blind comparison of mometasone furoate ointment 0, 1% and betamethasone dipropionate 0, 05% ointment was carried out in 60 patients with psoriasis vulgaris. Mometasone furoate ointment was applied once daily, and betamethasone ointment twice daily. Mometasone furoate produced good results in 85, 7%, and betamethasone in 85, 1% of evaluable patients (p>0, 05). Skin atrophy was more frequent in patients treated with betamethasone. According to the results obtained, we believe thast mometasone furoate is a valuable steroid in the treatment of psoriasis vulgaris.

mometasone furoate 0.1% ointment; betamethasone dipropionate 0; 05% ointment; psoriasis vulgaris

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

8

2000.

223-226

objavljeno

1330-027X

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost